On ECHEMI
Home > Drugs > Simcere Pharmaceutical Co., Ltd.
Simcere Pharmaceutical Co., Ltd.
  • Founded in:

    1998-09-10
  • Country:

    China China
  • Address:

    No. 99, Huakang Road, Jiangbei New District, Nanjing, Jiangsu Province
  • Tax NO.:

    91320100135665907G
  • Registered Funds:

    1.60281382 million yuan
  • Website:

  • Email:

Related Drugs
Yimu Tablets
Motherwort, rock sugar grass, salvia miltiorrhiza, etc.
Name Description Content CAS NO. Registered Holders
Motherwort Herb P.E.

0
Rock Candy Grass

0
Salvia Root P.E Tanshinone IIA 20%

0
Clemastine Fumarate Capsules
The main ingredient of this product and its chemical name are: [R-(R*, R*)]-1-methyl-2-[2-[1-(4-chlorophenyl)-1-phenethoxy]ethyl]-pyrrolidine (E)-2-butenedioate.
Name Description Content CAS NO. Registered Holders
Clemastine fumarate

This product is an H1 receptor antagonist, which can inhibit the permeability of capillaries and quickly relieve itching. This product also has anticholinergic and sedative effects.

More

This product is an H1 receptor antagonist, which can inhibit the permeability of capillaries and quickly relieve itching. This product also has anticholinergic and sedative effects.

14976-57-9 5
Biapenem
The main ingredient of this product is biapenem, without any excipients.
Name Description Content CAS NO. Registered Holders
Biapenem

120410-24-4 8
Biapenem for injection
Biapenem.
Name Description Content CAS NO. Registered Holders
Biapenem

Biapenem is a carbapenem antibiotic that exerts its antibacterial effect by inhibiting the synthesis of bacterial cell walls. It has broad-spectrum antibacterial activity against gram-positive and gram-negative aerobic and anaerobic bacteria. Biapenem is stable to human renal dehydropeptidase I (DHP-I) and can be administered alone without the need for combination with DHP-I inhibitors.

More

Biapenem is a carbapenem antibiotic that exerts its antibacterial effect by inhibiting the synthesis of bacterial cell walls. It has broad-spectrum antibacterial activity against gram-positive and gram-negative aerobic and anaerobic bacteria. Biapenem is stable to human renal dehydropeptidase I (DHP-I) and can be administered alone without the need for combination with DHP-I inhibitors.

120410-24-4 8
Oxaliplatin
Oxaliplatin
Name Description Content CAS NO. Registered Holders
Oxaliplatin

61825-94-3 56
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.